We previously showed that modified A/Puerto Rico/8/34 (PR8) influenza master strain had improved viral rescue and growth properties in African green monkey kidney (Vero) cell line by introducing NS gene of Vero-adapted A/England/1/53 (vaEng53). In the present study, it was found that the NS1 protein derived from vaEng53 was extensively accumulated in the nuclei than that of PR8. This accumulation was caused by 7 amino acid differences in C-terminal region of NS1 protein.
For the control of influenza, it is required the monitoring of virus infection in birds and mammals and the development of improved antiviral therapies and vaccines. The most widely used influenza vaccines are those made from subunits of inactivated viruses propagated in chicken embryonated eggs. Although routinely used to prepare influenza vaccines and diagnostic reagents, problems include the lack of reliable year-round supplies of high-quality eggs, the possible presence of pathogens, and the low growth of influenza virus in summer eggs (10) . In order to resolve this problem, we demonstrated that well-characterized African green monkey kidney (Vero) cell line was available for cell-based vaccine production with reverse genetics as an alternative method. The nonstructural (NS) protein gene derived from Vero-adapted virus contributed effective viral growth in early stage of infection (11) . In the present study, we investigated the relationship between localization of NS1 protein and growth kinetics of virus with mutant NS genes in Vero cells.
The plasmids carrying the eight gene segments of PR8 (H1N1) virus (pHW191 to pHW198) and plasmid carrying NS gene derived from Vero-adapted A/England/1/53 (H1N1) (vaEng53) (pHW/vaEng53-NS) (11) were used for the rescue of mutant viruses. Chimeric NS genes were constructed and modified by swapping first half and second half of NcoI or SspI digested fragments between PR8 and vaEng53 NS genes, respectively (Fig.1) . Virus rescue and viral growth kinetics in Vero cells was performed by following the method previously described (11) . Nuclear localization of each mutant NS1 protein was detected by immunofluorecent assay (6) . Briefly, the viruses with different mutant NS gene were inoculated on confluent Vero cells with a multiplicity of infection (MOI) of 1 pfu/cell. Three, five, and nine hours post infection, cells were fixed with methanol and reacted with anti-NS1 monoclonal antibody (3). NS1 protein was detected with Alexa Fluor-488 goat anti-mouse IgG antibody (Invitrogen).
To confirm the effect of the replacement of the NS gene segment in PR8 on subsequent virus amplification in Vero cells, we tested triplicate samples of near-confluent Vero cells with PR8 and PR8/vaEng53-NS at a low MOI (=0.01) and monitored virus replication by assaying culture supernatants every 12 h. As shown in Fig. 2 , vaEng53 NS gene was confirmed to contribute to the effective growth in Vero cells in early stage of virus replication. We, then, constructed carrying chimeric NS genes swapped the NcoI fragments between PR8 and vaEng53 NS genes in order to determine which region of the NS1 protein would be required for growth in early stage (Fig. 1) . The mutant PR8 viruses with each chimeric NS gene were applied to assess the growth kinetics as above.
The mutant PR8 including PE1-NS chimeric NS gene showed similar growth kinetics to that of PR8/vaEng53-NS. On the other hand, the growth of virus with EP1-NS chimeric NS gene was identical with that of PR8 (Fig. 2a) . Moreover, to narrow the responsible region down for the phenomenon, two more chimeric NS genes were constructed by swapping SspI fragments (Fig. 1) .
Growth kinetics curves showed that PE2-NS gene gave a contribution for rapid replication of virus in Vero cells (Fig. 2b) . These results indicate that near C-terminal region of NS1 protein is responsible for the rapid growth of the virus in Vero cells.
Amino acid alignment analysis revealed 15 amino acid differences on the NS1 protein between PR8 and vaEng53 ( Fig. 1) . Since 8 out of 15 amino acids did not affect to viral growth in Vero cells, the remaining 7 amino acid differences would be responsible to this phenomenon. We, then, focused on the nuclear localizing signal 2 (NLS2), PKQKRK motif (7) of the NS1 protein because the RNA binding domain, NLS1, and the effecter domain (described below and Fig. 1 ) were respectively common between both NS1 proteins. One amino acid difference was found in NLS2 between PR8 (PKQKRE) and vaEng53 (PKQKRK) NS1 proteins. To assess the localization of the NS1 protein in Vero cells, the mutant viruses were inoculated in Vero cells and NS1 protein was detected by immunofluorescence assay in different time points. As shown in Fig. 3 , the NS1 protein derived from vaEng53 NS gene was detected in three hours post inoculation in Vero cells but not that of PR8. Five hours post inoculation, almost all of NS1 protein from vaEng53 NS gene was accumulated in the nuclei of the cells with stronger signal than that of PR8. Four more hours later, the NS1 protein of PR8 was detected both in the nuclei and cytoplasm. Interestingly, NS1 protein from vaEng53 NS gene was still observed in the nuclei with strong signal at the same time point. In addition, PE1-NS1 and PE2-NS1 proteins were also detected similarly in the nuclei as that of vaEng53 NS gene (data not shown).
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